On Wednesday, Abbott Laboratories (NYSE:ABT) reports second quarter adjusted EPS $0.46 versus $0.43. Company posted second quarter net sales up by 2.5 percent to $5.45 billion and its net profit plunged to $476 million.
Abbott Laboratories the worldwide pharmaceuticals and health-care Products Company will report its newest results before markets open on Wednesday. According to Wall Street, estimate earnings are anticipated to be $0.44 per share, as compared with $1.08 per diluted share reported in the period of previous year. In the previous quarter, the company reported a profit of $544 million or $0.34 per share, declined from $1.24 billion a year ago. But net sales increased to 1.8%, almost $5.4 billion logging a gain of 3.5% from the same period a year ago excluding currency impacts.
Stock of Abbott Laboratories (NYSE:ABT) advanced 0.62% in last trading session and is closed $35.70 with average volume 7.36 million shares. Abbott Laboratories generated income of $772.70 million in last twelve months and sales of $ 21.59 billion. Analytic Ratios; Price to sales ratio of ABT in past twelve months was calculated as 2.57 and price to cash ratio as 6.51. ABT return on equity ratio is recorded as 20.90% and its return on assets is 9.00%.